Market revenue in 2022 | USD 650.0 million |
Market revenue in 2030 | USD 1,193.5 million |
Growth rate | 7.9% (CAGR from 2022 to 2030) |
Largest segment | Electrochemical |
Fastest growing segment | Electrochemical |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Thermal, Electrochemical, Piezoeletric, Optical |
Key market players worldwide | Bio-Rad Laboratories Inc, Medtronic PLC, Abbott Laboratories, Biosensors, Pinnacle Financial Partners Inc, DuPont Nutrition & Biosciences, Johnson & Johnson, Koninklijke Philips NV, Nova Biomedical, Koch Industries, TDK Corp, Siemens AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biosensors market will help companies and investors design strategic landscapes.
Electrochemical was the largest segment with a revenue share of 70.23% in 2022. Horizon Databook has segmented the Australia biosensors market based on thermal, electrochemical, piezoeletric, optical covering the revenue growth of each sub-segment from 2018 to 2030.
A wearable smart patch has been developed in Australia, which will help people suffering from chronic diseases such as type 2 diabetes by gathering data like how the patient’s body responds to various diets. The data is then sent to the app, which helps users in tracking precisely how their body reacts to various diets.
In 2016, Federal Election, the Australian government promised to subsidize the Continuous Glucose Monitoring (CGM) technology for assisting children and adults under the age of 21 years, who are facing challenges in managing their type 1 diabetes.
Furthermore, SMR Automotive will work with other local players to develop a novel diagnostic biosensor for bladder cancer. In April 2020, Australian Researchers developed the world’s first biosensor that has the ability to monitor changes in pH levels in cancer and stroke patients.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia biosensors market , including forecasts for subscribers. This country databook contains high-level insights into Australia biosensors market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account